Published in PLoS Med on November 29, 2011
Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med (2011) 2.37
The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa. PLoS One (2013) 1.69
Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services. PLoS Med (2011) 1.58
Systematic Monitoring of Voluntary Medical Male Circumcision Scale-up: adoption of efficiency elements in Kenya, South Africa, Tanzania, and Zimbabwe. PLoS One (2014) 1.54
Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med (2011) 1.51
Voluntary medical male circumcision in resource-constrained settings. Nat Rev Urol (2015) 1.37
Surgical efficiencies and quality in the performance of voluntary medical male circumcision (VMMC) procedures in Kenya, South Africa, Tanzania, and Zimbabwe. PLoS One (2014) 1.30
Status of voluntary medical male circumcision in Kenya: findings from 2 nationally representative surveys in Kenya, 2007 and 2012. J Acquir Immune Defic Syndr (2014) 1.18
Narrative review of models and success factors for scaling up public health interventions. Implement Sci (2015) 1.12
Attitudes, perceptions and potential uptake of male circumcision among older men in Turkana County, Kenya using qualitative methods. PLoS One (2014) 1.11
Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med (2013) 1.08
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Nursing and midwifery regulatory reform in east, central, and southern Africa: a survey of key stakeholders. Hum Resour Health (2013) 1.03
Evidence-based identification of key beliefs explaining adult male circumcision motivation in Zimbabwe: targets for behavior change messaging. AIDS Behav (2014) 0.98
Work experience, job-fulfillment and burnout among VMMC providers in Kenya, South Africa, Tanzania and Zimbabwe. PLoS One (2014) 0.94
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J (2016) 0.94
Scaling-up voluntary medical male circumcision - what have we learned? HIV AIDS (Auckl) (2014) 0.91
Task shifting redefined: removing social and structural barriers to improve delivery of HIV services for people who inject drugs. Harm Reduct J (2013) 0.86
Sociocultural and individual determinants for motivation of sexual and reproductive health workers in Papua New Guinea and their implications for male circumcision as an HIV prevention strategy. Hum Resour Health (2013) 0.84
Scale-Up of Early Infant Male Circumcision Services for HIV Prevention in Lesotho: A Review of Facilitating Factors and Challenges. Glob Health Sci Pract (2016) 0.82
Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi. J Acquir Immune Defic Syndr (2016) 0.81
Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training. BMC Health Serv Res (2016) 0.79
Feasibility and validity of telephone triage for adverse events during a voluntary medical male circumcision campaign in Swaziland. BMC Public Health (2014) 0.78
Motivations for entering and remaining in volunteer service: findings from a mixed-method survey among HIV caregivers in Zambia. Hum Resour Health (2015) 0.77
Voice-Message-Based mHealth Intervention to Reduce Postoperative Penetrative Sex in Recipients of Voluntary Medical Male Circumcision in the Western Cape, South Africa: Protocol of a Randomized Controlled Trial. JMIR Res Protoc (2016) 0.77
A program evaluation report of a rapid scale-up of a high-volume medical male circumcision site, KwaZulu-Natal, South Africa, 2010-2013. BMC Health Serv Res (2015) 0.76
Easy, Faster, and Not Bloody: Providers' Perceptions on PrePex™ in South Africa. J Assoc Nurses AIDS Care (2016) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
The World Health Report 2006: working together for health. Educ Health (Abingdon) (2006) 39.73
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Human resources for health: overcoming the crisis. Lancet (2004) 27.45
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS (2000) 8.94
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health (2010) 6.48
Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One (2011) 2.79
A model for the roll-out of comprehensive adult male circumcision services in African low-income settings of high HIV incidence: the ANRS 12126 Bophelo Pele Project. PLoS Med (2010) 2.43
Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011. PLoS Med (2011) 2.31
Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania. PLoS Med (2011) 2.12
The exodus of health professionals from sub-Saharan Africa: balancing human rights and societal needs in the twenty-first century. Nurs Inq (2007) 1.35
Africa's neglected surgical workforce crisis. Lancet (2008) 1.27
Workforce biggest barrier to roll-out of male circumcision. Lancet (2007) 1.22
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ (2006) 5.90
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol (2006) 4.68
The effects of local review on informed consent documents from a multicenter clinical trials consortium. Control Clin Trials (2003) 3.30
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. Am J Respir Crit Care Med (2004) 2.40
Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med (2011) 2.37
Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011. PLoS Med (2011) 2.31
Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania. PLoS Med (2011) 2.12
Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis (2009) 1.99
Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry (2006) 1.94
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol (2006) 1.78
Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol (2007) 1.78
Women's views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries. BMC Public Health (2012) 1.69
Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One (2011) 1.68
Universal HIV testing and counselling in Africa. Lancet (2008) 1.67
Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One (2011) 1.60
Why are women still aborting outside designated facilities in metropolitan South Africa? BJOG (2005) 1.60
Recent patterns in population-based HIV prevalence in Swaziland. PLoS One (2013) 1.58
Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services. PLoS Med (2011) 1.58
Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health Aff (Millwood) (2011) 1.52
Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med (2011) 1.51
The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change. BJOG (2005) 1.49
Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation. J Virol (2007) 1.47
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med (2007) 1.47
During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Aff (Millwood) (2011) 1.46
Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr (2012) 1.43
Is polygamy really benign? AIDS (2010) 1.41
Associations between mode of HIV testing and consent, confidentiality, and referral: a comparative analysis in four African countries. PLoS Med (2012) 1.35
Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr (2012) 1.28
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. Antimicrob Agents Chemother (2009) 1.27
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine (2012) 1.26
Status of voluntary medical male circumcision in Kenya: findings from 2 nationally representative surveys in Kenya, 2007 and 2012. J Acquir Immune Defic Syndr (2014) 1.18
Impaired mitochondrial respiration and protein nitration in the rat hippocampus after acute inhalation of combustion smoke. Toxicol Appl Pharmacol (2008) 1.18
The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. J Immunol (2005) 1.17
Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services. J Acquir Immune Defic Syndr (2014) 1.15
Influence of nativity status on breast cancer risk among US black women. J Urban Health (2006) 1.13
A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance. J Acquir Immune Defic Syndr (2014) 1.08
Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDS (2013) 1.07
Part 3: Adult Basic Life Support and Automated External Defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation (2015) 1.06
Health care priority setting in Norway a multicriteria decision analysis. BMC Health Serv Res (2012) 1.04
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists. Bioorg Med Chem (2006) 1.02
Notes from the Field: Tetanus Cases After Voluntary Medical Male Circumcision for HIV Prevention - Eastern and Southern Africa, 2012-2015. MMWR Morb Mortal Wkly Rep (2016) 1.02
Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa. J Fam Plann Reprod Health Care (2008) 1.01
Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod (2008) 1.00
Characterization of ocular tissues using microindentation and hertzian viscoelastic models. Invest Ophthalmol Vis Sci (2011) 0.98
Male circumcision programmes in Kenya: lessons from the Kenya AIDS Indicator Survey 2007. Bull World Health Organ (2012) 0.98
Medical abortion: the possibilities for introduction in the public sector in South Africa. Reprod Health Matters (2005) 0.96
Populations at increased risk for HIV infection in Kenya: results from a national population-based household survey, 2012. J Acquir Immune Defic Syndr (2014) 0.96
Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep (2010) 0.96
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data. J Acquir Immune Defic Syndr (2008) 0.96
Factors associated with acceptability of HIV self-testing among health care workers in Kenya. AIDS Behav (2014) 0.95
A Randomized Evaluation of a Demand Creation Lottery for Voluntary Medical Male Circumcision Among Adults in Tanzania. J Acquir Immune Defic Syndr (2016) 0.94
Socio-economic determinants of HIV testing and counselling: a comparative study in four African countries. Trop Med Int Health (2013) 0.91
HIV prevention in care and treatment settings: baseline risk behaviors among HIV patients in Kenya, Namibia, and Tanzania. PLoS One (2013) 0.90
Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection. J Virol (2010) 0.89
Mechanical interferometry imaging for creep modeling of the cornea. Invest Ophthalmol Vis Sci (2011) 0.88
Quantification of biomass and cell motion in human pluripotent stem cell colonies. Biophys J (2013) 0.88
Part 3: Adult basic life support and automated external defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation (2015) 0.88
Microbicides 2008 conference: from discovery to advocacy. AIDS Res Ther (2008) 0.88
Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells. Sci Technol Adv Mater (2013) 0.87
Effect of chronic hyperghrelinemia on ingestive action of ghrelin. Am J Physiol Regul Integr Comp Physiol (2005) 0.87
Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity. Bioorg Med Chem Lett (2008) 0.86
Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr (2013) 0.85
Macaque long-term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus. J Virol (2010) 0.85
CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller. Retrovirology (2012) 0.84
Image analysis and length estimation of biomolecules using AFM. IEEE Trans Inf Technol Biomed (2012) 0.84
Implementation and Operational Research: Evaluation of Loss-to-Follow-up and Postoperative Adverse Events in a Voluntary Medical Male Circumcision Program in Nyanza Province, Kenya. J Acquir Immune Defic Syndr (2015) 0.83
HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya. J Acquir Immune Defic Syndr (2015) 0.83
Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy. J Acquir Immune Defic Syndr (2013) 0.83
A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers. AIDS (2015) 0.83
Sexually transmitted infections among HIV-infected adults in HIV care programs in Kenya: a national sample of HIV clinics. Sex Transm Dis (2013) 0.82
Rapidly quantifying drug sensitivity of dispersed and clumped breast cancer cells by mass profiling. Analyst (2012) 0.82
Evaluation of loss-to-follow-up and post-operative adverse events in a voluntary medical male circumcision program in Nyanza Province, Kenya. J Acquir Immune Defic Syndr (2015) 0.82